An Integrated Microfluidic Platform for Cholangiocarcinoma Diagnosis from Clinical Bile Juice Samples by Utilizing Multiple Affinity Reagents
Published in Proceedings of 2020 IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (NEMS), 2020
Abstract
We present an integrated microfluidic platform for rapid and accurate cholangiocarcinoma (CCA) diagnosis from clinical bile juice samples. The platform utilizes multiple affinity reagents to capture and detect disease-specific biomarkers, demonstrating superior diagnostic performance compared to conventional methods.
Conference Details
- Conference: IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (NEMS)
- Date: September 27, 2020
- Status: First Author
Technical Contributions
- Development of multilayer microfluidic device architecture
- Integration of multiple affinity-based capture mechanisms
- Real-time label-free biomarker detection
- Validation with clinical bile samples from CCA patients
- Compact, point-of-care diagnostic capability
Impact
This work demonstrates the potential of microfluidic technology for enabling rapid, accurate, and accessible cholangiocarcinoma diagnosis in clinical settings.
Recommended citation: Tsung-Han Lu et al. (2020). "An Integrated Microfluidic Platform for Cholangiocarcinoma Diagnosis from Clinical Bile Juice Samples by Utilizing Multiple Affinity Reagents." In Proceedings of the 2020 IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (NEMS).
Download Paper